ABARCEO PHARMA AB
Abarceo Pharma is a spin out of Lund University Diabetes Center and is located in Malmo Sweden. Scientific founders Prof. Claes Wollheim, MD and Associate Prof. Albert Salehi are world-class experts in beta cell biology. Abarceo Pharma is a Lund University Holding company and was founded in December 2017. The company is dedicated to developing novel therapeutics for type-2 diabetes based upon a deep molecular and genetic understanding of the disease.
ABARCEO PHARMA AB
Industry:
Biotechnology Pharmaceutical Therapeutics
Address:
Malmö, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.abarceo.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins
Current Employees Featured
Founder
Official Site Inspections
http://www.abarceo.com
- Host name: webcluster2.webpod13-cph3.one.com
- IP address: 46.30.213.125
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Abarceo Pharma AB"
Management | Abarceo Pharma
Abarceo Pharma AB. Medeon Science Park Per Albin Hanssons vä 41, 205 12 Malmö, Sweden. Email: [email protected]. Abarceo Pharma is a Lund University Holding company and was …See details»
Abarceo Pharma AB - Crunchbase Company Profile & Funding
Abarceo Pharma is a spin out of Lund University Diabetes Center and is located in Malmo Sweden. Scientific founders Prof. Claes Wollheim, MD and Associate Prof. Albert Salehi are …See details»
Board Members | Abarceo Pharma
Abarceo Pharma is a spin-out of Lund University Diabetes Center founded in 2017 by Prof. Claes Wollheim, MD, and Associate Prof. Albert Salehi world-renowned scientists in diabetes research and beta-cell biology. ... Before …See details»
Abarceo Pharma AB - Org Chart, Teams, Culture & Jobs - The Org
Abarceo Pharma is a spin out of Lund University Diabetes Center and is located in Malmo Sweden. Scientific founders Prof. Claes Wollheim, MD and Associate Prof. Albert Salehi are …See details»
Abarceo Pharma AB - LinkedIn
Abarceo Pharma AB | 577 followers on LinkedIn. Developing the first disease modifying and durable treatment for type 2 and type 1 diabetes. | Abarceo is a preclinical stage company. …See details»
Abarceo Pharma AB - Home
Abarceo Pharma AB. Abarceo Pharma is developing a small molecule technology platform for the treatment of mitochondrial dysfunction, with an initial focus on T2D. KONTAKT CEO Kristian …See details»
Abarceo Pharma AB, Financial Info, Board and Management, …
Newsletter. (c) Pateleon AB 2020 All Rights ReservedSee details»
Abarceo Pharma - VentureRadar
Abarceo Pharma is a spin-out of Lund University Diabetes Center and is located in Malmo Sweden. Scientific founders Prof. Claes Wollheim, MD, and Associate Prof. Albert Salehi are …See details»
Abarceo Pharma AB Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Abarceo Pharma AB of Malmö, Skåne. Get the latest business insights from Dun & Bradstreet.See details»
Abarceo Pharma Company Profile 2024: Valuation, Funding
Abarceo Pharma General Information Description. Developer of novel therapeutics designed to offer the treatment of type-2 diabetes. The company's therapeutics revive dysfunctional beta …See details»
About | Abarceo Pharma
Abarceo Pharma is a spin-out of Lund University Diabetes Center founded in 2017 by Prof. Claes Wollheim, MD, and Associate Prof. Albert Salehi world-renowned scientists in diabetes …See details»
Abarceo Pharma - Overview, News & Similar companies - ZoomInfo
Who is Abarceo Pharma. Scientific founders Prof. Claes Wollheim, MD, and Associate Prof. Albert Salehi are world-class experts in beta cell biology. Abarceo Pharma is a L und University …See details»
Abarceo Pharma - Craft
Abarceo Pharma is a company that develops therapeutics for type-2 diabetes. It identifies VDAC1 as a key target in type-2 diabetes and develops antibodies and small-molecule inhibitors …See details»
Abarceo Pharma AB - Contacts, Employees, Board Members
Organization. Abarceo Pharma AB . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Abarceo Pharma | LU Innovation
Abarceo Pharma has identified a novel diabetes target and has elucidated the key to the revival of dysfunctional beta cells enabling a resetting of the beta cell to a functional and healthy state. …See details»
Home 2 | Abarceo Pharma
Abarceo Pharma is a spin-out of Lund University Diabetes Center and is located in Malmo Sweden. Scientific founders Prof. Claes Wollheim, MD, and Associate Prof. Albert Salehi are …See details»
Abarceo Pharma AB - Malmö, Sweden - bionity.com
Abarceo Pharma has identified a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic treatment to revert beta cells from dysfunctional to …See details»
Abarceo Pharma | Abarceo Pharma
Abarceo Pharma has identified a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic treatment to revert beta cells from dysfunctional to …See details»
News | Abarceo Pharma
Nov 14, 2024 Abarceo Pharma is a Lund University Holding company and was founded in December 2017 by Scientific founders Prof. Claes Wollheim, MD, and Associate Prof. Albert …See details»